UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934


       Date of Report (Date of earliest event reported) November 1, 2004
       ------------------------------------------------------------------


                               AVOCENT CORPORATION
-------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


       DELAWARE                          000-30575           91-2032368
------------------------------------------------------------------------------
 (State or other jurisdiction          (Commission         (IRS Employer
      of incorporation)                File Number)       Identification No.)


4991 CORPORATE DRIVE   HUNTSVILLE, AL                         35805
------------------------------------------------------------------------------
 (Address of principal executive offices)                   (Zip Code)

Registrant's telephone number, including area code     (256) 430-4000
                                                   ---------------------------

                                       n/a
------------------------------------------------------------------------------
         (Former name or former address, if changed since last report.)


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act
   (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
    (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
    Exchange Act (17 CFR 240.13e-4(c))








Item 7.01  Regulation FD Disclosure.


         On November 1, 2004, Avocent Corporation publicly disseminated a press
release announcing that its Board of Directors has approved a stock repurchase
program authorizing the repurchase of up to two million of its common shares.
The information contained in the press release is incorporated herein by
reference and furnished as Exhibit 99.9 hereto.


Item 9.01  Financial Statements and Exhibits.

(c) Exhibits.

         Exhibit Number             Description of Exhibit
         --------------             ----------------------
         99.9                       Press release issued November 1, 2004







                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                               AVOCENT CORPORATION

Date:  November 1, 2004
                                  By:  /s/ Douglas E. Pritchett
                                       -------------------------------------
                                       Douglas E. Pritchett
                                       Senior Vice President of Finance,
                                       Chief Financial Officer and Treasurer






                                 EXHIBIT INDEX


Exhibit                    Description
-------                    -----------
99.9                       Press Release dated November 1, 2004